Drug delivery systems against leishmaniasis? Still an open question

Author： Romero Eder L   Morilla Maria Jose  

Publisher： Informa Healthcare

ISSN： 1742-5247

Source： Expert Opinion on Drug Delivery, Vol.5, Iss.7, 2008-07, pp. : 805-823

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Drug delivery systems for the topical treatment of cutaneous leishmaniasis

By Carneiro Guilherme   Aguiar Marta Gontijo   Fernandes Ana Paula   Ferreira Lucas Antônio Miranda  

Expert Opinion on Drug Delivery, Vol. 9, Iss. 9, 2012-09 ,pp. : 1083-1097

Informa Healthcare

Access to resources Recommend Favorite

Drug delivery strategies for therapy of visceral leishmaniasis

By Gupta Swati   Pal Ajay   Vyas Suresh P  

Expert Opinion on Drug Delivery, Vol. 7, Iss. 3, 2010-03 ,pp. : 371-402

Informa Healthcare

Access to resources Recommend Favorite

Recent developments in leishmaniasis vaccine delivery systems

By Bhowmick Sudipta   Ali Nahid  

Expert Opinion on Drug Delivery, Vol. 5, Iss. 7, 2008-07 ,pp. : 789-803

Informa Healthcare

Access to resources Recommend Favorite

Gastroretentive drug delivery systems

By Streubel Alexander   Siepmann Juergen   Bodmeier Roland  

Expert Opinion on Drug Delivery, Vol. 3, Iss. 2, 2006-03 ,pp. : 217-233

Informa Healthcare

Access to resources Recommend Favorite

Intracochlear drug delivery systems

By Borenstein Jeffrey T  

Expert Opinion on Drug Delivery, Vol. 8, Iss. 9, 2011-09 ,pp. : 1161-1174

Informa Healthcare

Access to resources Recommend Favorite